Civic Intelligence

Transboundary Animal Biologics Inc

EIN 90-0401119 • 501(c)3 • Ames, IA

Profile

The corporation was organized for the purpose of promoting the public interest through enhancing the availability of veterinary biologics for transboundary diseases.

3515 University BlvdAmes, IA 50010-9110

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

75th percentile

0.06x

Higher debt load relative to assets than 75% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Liabilities / Revenue

75th percentile

0.03x

Higher debt load relative to revenue than 75% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Net Margin

15th percentile

-45%

Higher net margin than 15% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Top Officer Pay

94th percentile

$55,000

Higher top officer pay than 94% of similar nonprofits.

Top officer pay equals 76.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2025

Asset Growth

21st percentile

-45%

Faster asset growth than 21% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Revenue Growth

23rd percentile

-39%

Faster revenue growth than 23% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Assets

Down

$38,722

Down $31,480 (-45%) from 2024

Liabilities

Up

$2,134

Up $1,135 (+114%) from 2024

Net Assets

Down

$36,588

Down $32,615 (-47%) from 2024

Revenue

Down

$72,400

Down $46,209 (-39%) from 2024

Expenses

Down

$105,015

Down $10,297 (-8.9%) from 2024

Net Income

Down

-$32,615

Down $35,912 (-1089%) from 2024

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$200K$150K$100K$50K$0Assets 2010: $145,662Liabilities 2010: $0Net Assets 2010: $145,6622010Assets 2011: $142,336Liabilities 2011: $796Net Assets 2011: $141,5402011Assets 2012: $150,050Liabilities 2012: $11,432Net Assets 2012: $138,6182012Assets 2013: $143,510Liabilities 2013: $5,778Net Assets 2013: $137,7322013Assets 2014: $98,216Liabilities 2014: $5,778Net Assets 2014: $92,4382014Assets 2015: $104,735Liabilities 2015: $2,530Net Assets 2015: $102,2052015Assets 2016: $81,596Liabilities 2016: $2,525Net Assets 2016: $79,0712016Assets 2017: $62,054Liabilities 2017: $2,066Net Assets 2017: $59,9882017Assets 2018: $64,851Liabilities 2018: $335Net Assets 2018: $64,5162018Assets 2019: $54,168Liabilities 2019: $1,033Net Assets 2019: $53,1352019Assets 2020: $59,973Liabilities 2020: $308Net Assets 2020: $59,6652020Assets 2021: $53,955Liabilities 2021: $2,066Net Assets 2021: $51,8892021Assets 2022: $56,326Liabilities 2022: $616Net Assets 2022: $55,7102022Assets 2023: $66,522Liabilities 2023: $616Net Assets 2023: $65,9062023Assets 2024: $70,202Liabilities 2024: $999Net Assets 2024: $69,2032024Assets 2025: $38,722Liabilities 2025: $2,134Net Assets 2025: $36,5882025

Highlighted filing

2025

Assets$38,722
Liabilities$2,134
Net Assets$36,588

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$100K$0-$100KExpenses 2010: $129,9142010Revenue 2011: $176,872Expenses 2011: $180,994Net Income 2011: -$4,1222011Revenue 2012: $44,948Expenses 2012: $47,870Net Income 2012: -$2,9222012Revenue 2013: $169,835Expenses 2013: $170,721Net Income 2013: -$8862013Revenue 2014: $37,496Expenses 2014: $82,454Net Income 2014: -$44,9582014Revenue 2015: $75,130Expenses 2015: $65,363Net Income 2015: $9,7672015Revenue 2016: $60,652Expenses 2016: $83,786Net Income 2016: -$23,1342016Revenue 2017: $39,253Expenses 2017: $58,336Net Income 2017: -$19,0832017Revenue 2018: $40,377Expenses 2018: $35,849Net Income 2018: $4,5282018Revenue 2019: $21,171Expenses 2019: $32,552Net Income 2019: -$11,3812019Revenue 2020: $42,454Expenses 2020: $35,924Net Income 2020: $6,5302020Revenue 2021: $48,082Expenses 2021: $55,858Net Income 2021: -$7,7762021Revenue 2022: $60,127Expenses 2022: $56,306Net Income 2022: $3,8212022Revenue 2023: $66,472Expenses 2023: $56,276Net Income 2023: $10,1962023Revenue 2024: $118,609Expenses 2024: $115,312Net Income 2024: $3,2972024Revenue 2025: $72,400Expenses 2025: $105,015Net Income 2025: -$32,6152025

Highlighted filing

2025

Revenue$72,400
Expenses$105,015
Net Income-$32,615

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$0.39$0.02$0.37$0.72$1.05$0.33
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.70$0.01$0.69$1.19$1.15$0.03
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.67$0.01$0.66$0.66$0.56$0.10
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.56$0.01$0.56$0.60$0.56$0.04
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.54$0.02$0.52$0.48$0.56$0.08
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.60$0.00$0.60$0.42$0.36$0.07
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.54$0.01$0.53$0.21$0.33$0.11
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.65$0.00$0.65$0.40$0.36$0.05
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.62$0.02$0.60$0.39$0.58$0.19
2016Detailed filing. Detailed filing data is available for this year.$0.82$0.03$0.79$0.61$0.84$0.23
2015Detailed filing. Detailed filing data is available for this year.$1.05$0.03$1.02$0.75$0.65$0.10
2014Detailed filing. Detailed filing data is available for this year.$0.98$0.06$0.92$0.37$0.82$0.45
2013Detailed filing. Detailed filing data is available for this year.$1.44$0.06$1.38$1.70$1.71$0.01
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.50$0.11$1.39$0.45$0.48$0.03
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.42$0.01$1.42$1.77$1.81$0.04
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.46$0.00$1.46$1.30
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2025 to Dec 31, 2025
Signed
Jan 29, 2026
Return Version
2025v4.0
Gross Receipts
$72,400
Mission and Program Overview

Mission

The corporation was organized for the purpose of promoting the public interest through enhancing the availability of veterinary biologics for transboundary diseases.

Program Services

DescriptionGrantsExpenses
THE CORPORATION WAS ORGANIZED FOR THE PURPOSE OF PROMOTING THE PUBLIC INTEREST THROUGH ENHANCING THE AVAILABILITY OF VETERINARY BIOLOGICS FOR TRANSBOUNDARY DISEASES.-$103,265
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
CAROL J GAYLONVice PresidePT$55,000-$55,000
JAMES A ROTHPresidentPT$40,000-$40,000
Filing and Contact Details

Filer

Filer Name
Transboundary Animal Biologics Inc
EIN
90-0401119
Phone
5154517617
Address
3515 UNIVERSITY BLVD, AMES, IA 50010-9110

Signing Officer

Name
James a Roth
Title
President
Phone
5154517617
Signed
2026-01-29
Discuss with paid preparer
Yes

Preparer

Firm
Pyle & Associates Pc
Address
707 5TH ST STE 201, AMES, IA 50010
Preparer
Susan L Pyle
Phone
5152322193
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses insurance 825 website expense 134 total 959

Form 990-ez, Part II, Line 24

Start up and organization expenses 2,358 2,358 less accumulated amortization 2,358 2,358 total 0 0

Form 990-ez, Part II, Line 26

Accrued payroll taxes 999 2,134

Form 990-ez, Part III

The corporation was organized for the purpose of promoting the public interest through enhancing the availability of veterinary biologics for transboundary diseases.

Raw XML Appendix131 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/AddressChangeInd0X
IRS990EZ/BooksInCareOfDetail/PersonNm0JAMES A ROTH
IRS990EZ/BooksInCareOfDetail/PhoneNum05154517617
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt03515 UNIVERSITY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0AMES
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0IA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd0500109110
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt070202
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt038722
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt020
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-32615
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01750
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt070202
IRS990EZ/Form990TotalAssetsGrp/EOYAmt038722
IRS990EZ/GrossReceiptsAmt072400
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt0380
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt069203
IRS990EZ/NetAssetsOrFundBalancesEOYAmt036588
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt069203
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt036588
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt110.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt040000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt155000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JAMES A ROTH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1CAROL J GAYLON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE PRESIDE
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt0959
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE CORPORATION WAS ORGANIZED FOR THE PURPOSE OF PROMOTING THE PUBLIC INTEREST THROUGH ENHANCING THE AVAILABILITY OF VETERINARY BIOLOGICS FOR TRANSBOUNDARY DISEASES.
IRS990EZ/ProgramServiceRevenueAmt072000
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE CORPORATION WAS ORGANIZED FOR THE PURPOSE OF PROMOTING THE PUBLIC INTEREST THROUGH ENHANCING THE AVAILABILITY OF VETERINARY BIOLOGICS FOR TRANSBOUNDARY DISEASES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0103265
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt0102306
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt0999
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt02134
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0105015
IRS990EZ/TotalProgramServiceExpensesAmt0103265
IRS990EZ/TotalRevenueAmt072400
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt072020
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0118070
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt066000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt060000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt048000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0364090
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0380
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0539
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0472
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0127
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt082
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01600
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt0364090
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.99560
IRS990ScheduleA/PublicSupportPY170Pct00.99610
IRS990ScheduleA/PublicSupportTotal170Amt0364090
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt072020
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0118070
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt066000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt060000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt048000
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0364090
IRS990ScheduleA/TotalSupportAmt0365690
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES INSURANCE 825 WEBSITE EXPENSE 134 TOTAL 959
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1START UP AND ORGANIZATION EXPENSES 2,358 2,358 LESS ACCUMULATED AMORTIZATION 2,358 2,358 TOTAL 0 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2ACCRUED PAYROLL TAXES 999 2,134
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE CORPORATION WAS ORGANIZED FOR THE PURPOSE OF PROMOTING THE PUBLIC INTEREST THROUGH ENHANCING THE AVAILABILITY OF VETERINARY BIOLOGICS FOR TRANSBOUNDARY DISEASES.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0JAMES A ROTH
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum05154517617
ReturnHeader/BusinessOfficerGrp/SignatureDt02026-01-29
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0TRANSBOUNDARY ANIMAL BIOLOGICS INC
ReturnHeader/Filer/BusinessNameControlTxt0TRAN
ReturnHeader/Filer/EIN0900401119
ReturnHeader/Filer/PhoneNum05154517617
ReturnHeader/Filer/USAddress/AddressLine1Txt03515 UNIVERSITY BLVD
ReturnHeader/Filer/USAddress/CityNm0AMES
ReturnHeader/Filer/USAddress/StateAbbreviationCd0IA
ReturnHeader/Filer/USAddress/ZIPCd0500109110
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0812818495
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0PYLE & ASSOCIATES PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0707 5TH ST STE 201
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0AMES
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0IA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd050010
ReturnHeader/PreparerPersonGrp/PhoneNum05152322193
ReturnHeader/PreparerPersonGrp/PreparationDt02026-03-02
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0SUSAN L PYLE
ReturnHeader/ReturnTs02026-03-02T16:24:29-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02025-01-01
ReturnHeader/TaxPeriodEndDt02025-12-31
ReturnHeader/TaxYr02025

Document Assets

No mirrored PDF or thumbnail assets are attached yet.